Scribe Therapeutics, Inc.: 10-Q filed Sep 2, 2026

Form type
10-Q
Filing date
Sep 2, 2026
Accession number
0001193125-26-380191
Filer
Scribe Therapeutics, Inc. (CIK 1853921)